Literature DB >> 29436267

News and Notes From the 2009 Carrier Advisory Committee Meeting: Medical Necessity, Off-Label Chemotherapy, and More.

Barbara McAneny, Thomas Marsland, Kristen King.   

Abstract

A discussion of two compelling topics at this summer's Hematology-Oncology Carrier Advisory Committee Network Meeting: coverage for off-label uses of anticancer drugs and medical necessity for oral versus intravenous antiemetics.

Year:  2009        PMID: 29436267      PMCID: PMC2869178          DOI: 10.1200/JOP.091047

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  2 in total

1.  Recent developments in medicare coverage of off-label cancer therapies.

Authors: 
Journal:  J Oncol Pract       Date:  2009-01       Impact factor: 3.840

2.  Reimbursement for cancer treatment: coverage of off-label drug indications.

Authors: 
Journal:  J Clin Oncol       Date:  2006-05-22       Impact factor: 44.544

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.